PTK2 and cancer: Furthermore, we found that overexpression of CLCA2 inhibits NPC growth and metastasis in vitro and in vivo, and knockdown of CLCA2 by siRNA promotes NPC cell migration and invasion though activation of FAK, which is a key driving force in cancer progression.